About PIPr Therapeutics
PIPr Therapeutics is a private company based in Durham, North Carolina. It has reported $30,116,307 raised in five offerings on Form D since October 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 31, 2025 | Nov 12, 2025 | $1,499,995of $2.4M target | 3 | $499K | EquityRule 506(b) | Form D ↗ |
| Dec 21, 2020 | Dec 23, 2020amended Jun 15, 2022 | $18,877,921fully sold | 7 | $2.6M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 28, 2020 | Mar 4, 2020 | $1,738,391of $2.0M target | 4 | $434K | Debt, Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Mar 4, 2019 | Mar 8, 2019 | $5,000,000fully sold | 6 | $833K | EquityRule 506(b) | Form D ↗ |
| Sep 29, 2016 | Oct 14, 2016 | $3,000,000of $5.0M target | 5 | $600K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $30,116,307 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PIPr Therapeutics's Form D filed Nov 12, 2025.
Earlier filings also listed St. John McGrath (director, last listed Jun 2022), E. Soderstrom (director, last listed Jun 2022), Christy Shaffer (director, last listed Jun 2022), Bridget Martell (president and director, last listed Jun 2022), Moncef Slaoui (director, last listed Mar 2020), Marian Nakada (director, last listed Mar 2020), Jonathan Soderstrom (director, last listed Mar 2020) and James Rosen (president and director, last listed Mar 2020).